Source - RNS
RNS Number : 7668I
Consort Medical PLC
21 June 2017
 

21 June 2017

 

Consort Medical plc

 

Notification of Transactions of Directors or

Persons Discharging Managerial Responsibility and Connected Persons

 

 

 

On 20 June 2017 pursuant to the rules of the Consort Medical plc Performance Share Plan the following Directors/persons discharging managerial responsibilities ("PDMRs") of Consort Medical plc (the "Company"), were granted awards over ordinary shares at a share price of £10.67 ("Shares") in the Company as detailed against their name below:

 

 

Performance Share Plan Award

 

Director/PDMR

Number of Shares

Jon Glenn

45,385

Paul Hayes

29,990

Keyvan Djamarani

16,869

Manja Boerman

16,869

 

Each award was granted as a nil cost option.

 

Enquiries:       Michelle Palmer Assistant Company Secertary         01442 867920

Consort Medical plc is a leading, global, single source pharma services drug and delivery device company. We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.  

Our businesses  

Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, injectables and ocular products, and the manufacture of devices for the point of care diagnostics market. www.bespak.com.

Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners. www.aesica-pharma.com. 

We employ more than 2000 people globally of which 1400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). www.consortmedical.com

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jonathan Glenn

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p shares



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Grant of ordinary shares pursuant to the Consort Medical Performance Share Plan

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




0

45,385







d)

 

Aggregated information

n/a single transaction



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

20 June 2017

f)

 

Place of the transaction

 

Off market transaction

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul Hayes

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CFO

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p shares



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Grant of ordinary shares pursuant to the Consort Medical Performance Share Plan

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




0

29,990







d)

 

Aggregated information

n/a single transaction



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

20 June 2017

f)

 

Place of the transaction

 

Off market transaction

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Keyvan Djamarani

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Managing Director Bespak Division

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p shares



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Grant of ordinary shares pursuant to the Consort Medical Performance Share Plan

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




0

16,869







d)

 

Aggregated information

n/a single transaction



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

20 June 2017

f)

 

Place of the transaction

 

Off market transaction

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Manja Boerman

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Manging Director Aesica Division

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p shares



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Grant of ordinary shares pursuant to the Consort Medical Performance Share Plan

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




0

16,869







d)

 

Aggregated information

n/a single transaction



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

20 June 2017

f)

 

Place of the transaction

 

Off market transaction

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFFLFLDQFBBBD